Bruce Jackson
Stock Analyst at Benchmark
(0.97)
# 3,863
Out of 5,008 analysts
122
Total ratings
27.93%
Success rate
-20.93%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CV CapsoVision | Initiates: Speculative Buy | $5 | $4.71 | +6.16% | 1 | Jul 28, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $1.04 | +164.55% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $1.65 | +751.06% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.44 | +584.31% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $9.07 | +263.84% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $4.71 | +388.32% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $77.40 | +3.36% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $9.03 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $57.75 | +12.55% | 7 | Jan 13, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.65 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $4.63 | +547.95% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.45 | +176.61% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.53 | +96.08% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.16 | +131.48% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $0.68 | +4,339.18% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $4.37 | +1,273.00% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.84 | +1,923.81% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.18 | +1,933.90% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.67 | +646.49% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.65 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $26.72 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.73 | +21,347.72% | 1 | Aug 8, 2022 |
CapsoVision
Jul 28, 2025
Initiates: Speculative Buy
Price Target: $5
Current: $4.71
Upside: +6.16%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $1.04
Upside: +164.55%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.65
Upside: +751.06%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.44
Upside: +584.31%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $9.07
Upside: +263.84%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $4.71
Upside: +388.32%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $77.40
Upside: +3.36%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.03
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $57.75
Upside: +12.55%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.65
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $4.63
Upside: +547.95%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.45
Upside: +176.61%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.53
Upside: +96.08%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.16
Upside: +131.48%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $0.68
Upside: +4,339.18%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $4.37
Upside: +1,273.00%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.84
Upside: +1,923.81%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.18
Upside: +1,933.90%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.67
Upside: +646.49%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.65
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $26.72
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.73
Upside: +21,347.72%